Novyra Pharmachem Q2 FY27 Results: Net Profit ₹0 Cr
Novyra Pharmachem Ltd reported revenue from operations of ₹4.2 Cr and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Novyra Pharmachem Ltd reported revenue from operations of ₹4.2 Cr and net profit of ₹0 Cr for Q2 FY27.
Novyra Pharmachem will hold a board meeting on 2 November 2026 to consider unaudited Q2 results. Agenda items remain proposed until the meeting.
Novyra Pharmachem Ltd filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Novyra Pharmachem intimated BSE of a change in its official email ID under Reg 30. The update is purely administrative with no business or financial impact.
The company has officially changed its name from Bansisons Tea Industries Limited to Novyra Pharmachem Limited. This change reflects the company's expansion into the pharmaceutical sector.
Bansisons Tea Industries Ltd reported revenue from operations of ₹1.7 Cr and net profit of ₹0 Cr for Q1 FY27.